Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Urine metabolome profiling of immune-mediated inflammatory diseases.
BMC Med. 2016 Sep 8;14(1):133. doi: 10.1186/s12916-016-0681-8.
BMC Med. 2016.
PMID: 27609333
Free PMC article.
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era.
Nunes T, Etchevers MJ, Domènech E, García-Sánchez V, Ber Y, Peñalva M, Merino O, Nos P, Garcia-Planella E, Casbas AG, Esteve M, Taxonera Samsó C, Montoro Huguet M, Gisbert JP, Martín Arranz MD, García-Sepulcre MF, Barreiro-de Acosta M, Beltrán B, Alcaide Suárez N, Saro Gismera C, Cabriada JL, Cañas-Ventura A, Gomollón F, Panés J; Tobacco-Eneida Study Group of GETECCU.
Nunes T, et al. Among authors: casbas ag.
Aliment Pharmacol Ther. 2013 Oct;38(7):752-60. doi: 10.1111/apt.12440. Epub 2013 Aug 26.
Aliment Pharmacol Ther. 2013.
PMID: 23980933
Free article.
Item in Clipboard
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Peyrin-Biroulet L; STARDUST study group.
Danese S, et al.
Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 Feb 1.
Lancet Gastroenterol Hepatol. 2022.
PMID: 35120656
Clinical Trial.
Item in Clipboard
Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).
Marín-Jiménez I, Saro C, Díaz V, Acosta MB, Gómez-García M, Casbas AG.
Marín-Jiménez I, et al. Among authors: casbas ag.
Drugs Context. 2018 Mar 6;7:212505. doi: 10.7573/dic.212505. eCollection 2018.
Drugs Context. 2018.
PMID: 29535792
Free PMC article.
Item in Clipboard
IMPACT OF MESALAZINE ON THE RESPONSE TO COVID-19 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. RESULTS OF A PROSPECTIVE MULTICENTRE STUDY OF GETECCU (VACOVEII STUDY).
Deza DC, Julián Gomara AB, Biota EC, Beltrán B, Domènech E, Casbas AG, Mañosa M, Zabana Y, Alfaro LR, Romero EV, González EG, Sicilia B, Laredo V, Alcalá Escriche MJ, Velázquez LM, Iglesias RF, Pérez AP, Calafat M, Iturria SR, Yudego IM, Nieto YB, Mateo SG, Gisbert JP, Lidón RV, Arias L, Alfambra E, Roche PC, de Acosta MB, López SG.
Deza DC, et al. Among authors: casbas ag.
Gastroenterol Hepatol. 2024 Jan 12:S0210-5705(24)00017-7. doi: 10.1016/j.gastrohep.2023.12.012. Online ahead of print.
Gastroenterol Hepatol. 2024.
PMID: 38219960
English, Spanish.
Item in Clipboard
ECCO Topical Review: Roadmap to Optimal Peri-Operative Care in IBD.
Sebastian S, Segal JP, Hedin C, Pellino G, Kotze PG, Adamina M, Campmans-Kuijpers M, Davies J, de Vries AC, Casbas AG, El-Hussuna A, Juillerat P, Meade S, Millán M, Spinelli A.
Sebastian S, et al. Among authors: casbas ag.
J Crohns Colitis. 2023 Mar 18;17(2):153-169. doi: 10.1093/ecco-jcc/jjac129.
J Crohns Colitis. 2023.
PMID: 36055337
Free article.
Item in Clipboard
Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU.
Chaparro M, Garre A, Ricart E, Iglesias-Flores E, Taxonera C, Domènech E, Gisbert JP; ENEIDA study group.
Chaparro M, et al.
Aliment Pharmacol Ther. 2019 Feb;49(4):419-428. doi: 10.1111/apt.15114. Epub 2019 Jan 13.
Aliment Pharmacol Ther. 2019.
PMID: 30637837
Item in Clipboard
Cite
Cite